Mark Hutt
About Mark Hutt
Mark Hutt is the Sr. Director of Global Cell Therapy Quality Systems at Bristol Myers Squibb, with extensive experience in quality systems and training in the biotech and pharmaceutical industries.
Sr. Director, Global Cell Therapy Quality Systems at Bristol Myers Squibb
Mark Hutt serves as the Sr. Director of Global Cell Therapy Quality Systems at Bristol Myers Squibb, located in the Greater Seattle Area. In this role, he oversees the quality systems for cell therapy, ensuring the adherence to regulatory standards and optimizing quality frameworks across global operations. Hutt's leadership is instrumental in maintaining the high standards required in cell therapy quality systems and improving organizational compliance and performance.
Career at Bristol Myers Squibb
Prior to his current role, Mark Hutt worked at Bristol Myers Squibb as the Director of GMP Training & Documentation from 2019 to 2022. During this time, he was based in Seattle, Washington, where he developed and managed training programs to ensure compliance with Good Manufacturing Practices (GMP). Hutt was essential in documenting processes and protocols, enhancing the training initiatives, and ensuring regulatory adherence across all operations.
Professional Experience at Juno Therapeutics, Inc.
Mark Hutt was the Director of GMP Training at Juno Therapeutics, Inc. from 2018 to 2019. In this role, he was responsible for designing and implementing GMP training programs that optimized the company's operational efficiency and compliance. His efforts at Juno Therapeutics ensured that employees were well-trained in regulatory standards and protocols, thus enhancing overall quality and productivity.
Roles at Novartis
At Novartis, Mark Hutt held two significant positions from 2011 to 2018. Initially, he served as the Director of Training based in Broomfield, Colorado (2011-2013), and then as the Global Head of GxP Training for Sandoz, where he reported globally to Holzkirchen, Germany (2013-2018). In these roles, he was instrumental in driving the development and delivery of GxP training programs, which improved human and organizational performance on a global scale. His leadership facilitated the standardization and harmonization of processes across Novartis' global network, ensuring consistent quality practices.
Extensive Career at Amgen
Mark Hutt's career at Amgen spanned from 1996 to 2011, where he held various roles, including Manufacturing Associate, Manufacturing Manager, Training Specialist, Training Manager, Sr. Manager Training & Development, and Sr. Manager Learning and Performance. Throughout these roles, he was pivotal in developing training programs, optimizing manufacturing processes, and managing large teams. His contributions significantly impacted Amgen's compliance and improvement in quality systems.
Education and Advanced Studies
Mark Hutt pursued advanced studies at Colorado State University, where he is a Ph.D. Candidate in Organizational Leadership, Performance, and Change, with an expected graduation in 2023. He also obtained a Master's degree in Adult Education and Training from the same institution. Additionally, he holds a BS in Microbiology with a focus on Genetic Engineering from UC Santa Barbara. His diverse educational background underpins his expertise in organizational leadership and quality systems.